Ellen Tillotson is a Principal Process Engineer with extensive experience in biotechnology process engineering and drug substance manufacturing. Currently, they lead technical direction and capital project execution at Amgen, focusing on Drug Substance Manufacturing Systems. Previously, they held roles at Amgen and Genentech, where they managed groundbreaking projects and contributed to significant facility expansions and process improvements. Ellen earned a BS in Biomedical Engineering with a minor in Chemical Engineering from the University of Rochester, as well as dual master's degrees in Mechanical Engineering and Business Administration from the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices